A61P 25 - Drugs for disorders of the nervous system

Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2006
12/20/2006	CN1879811A Chinese medicinal composition for treating epilepsy
12/20/2006	CN1879782A Chinese medicinal preparation for increasing memory and improving eyesight and method for preparing same
12/20/2006	CN1879779A Insomnia-treating medicament and method for preparing same
12/20/2006	CN1879778A Headache-treating medicine
12/20/2006	CN1879768A Mind tranquilizing medicine
12/20/2006	CN1879767A Mind tranquilizing medicine
12/20/2006	CN1879750A Liver tonic and novel preparation method thereof
12/20/2006	CN1879734A A medicinal liquor for treating heart deficiency type insomnia and preparation method thereof
12/20/2006	CN1879732A Tranquilizing and sleep-inducing composition with spine date seed oil and cape jasmine oil and application thereof
12/20/2006	CN1879723A Meridian obstruction dredging pills
12/20/2006	CN1879718A A medicinal liquor for treating neurasthenic insomnia and preparation method thereof
12/20/2006	CN1879712A Novel use of asiaticoside in resisting anxiety and depression
12/20/2006	CN1879697A Pharmaceutical composition for treating senile dementia
12/20/2006	CN1879692A Novel use of camphor tree in toxin expelling, detoxication, cancer prevention, cancer resistance and beauty treatment
12/20/2006	CN1879660A A method for preparing novel chemical substance with anti-fertility and pain relieving activity
12/20/2006	CN1879653A Bezoar nano-powder preparation process and pharmaceutical preparation thereof
12/20/2006	CN1879652A Dried material and method for the manufacture thererof
12/20/2006	CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol
12/20/2006	CN1879629A Estrogen replacement therapy
12/20/2006	CN1879624A 5-ht 1a receptor subtype agonists
12/20/2006	CN1879617A Modulating multiple lineage kinase proteins
12/20/2006	CN1879608A Bioadhesive progressive hydration tablets
12/20/2006	CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/20/2006	CN1290847C Aza-arylpiperazines
12/20/2006	CN1290846C Pyrazolo[1,5-a]pyridines and medicaments containing thereof
12/20/2006	CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
12/20/2006	CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris
12/20/2006	CN1290816C Hyperforin derivatives, the use thereof and formulations containing them
12/20/2006	CN1290566C Depression treating medicinal formulation and its preparation process
12/20/2006	CN1290539C Preparation of Gebai liquid for sober up
12/20/2006	CN1290532C Chinese medicine preparation for treating neurosis
12/20/2006	CN1290495C Lipid microspherical asarol preparation and its preparation process
12/19/2006	US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
12/19/2006	US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
12/19/2006	US7151111 Amine oxidase inhibitor; Alzheimer's disease
12/19/2006	US7151109 Psychological disorders; anxiolytic agents; antidepressants
12/19/2006	US7151107 A quaternary ammonium salts of 1-{2-(3'-chlorobiphenyl-4-yl)-2-oxoethyl}-4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydropyridine; used as neuroprotectants, for prophylaxis of brain and nervous system disorders, Alzheimer's disease, senile dementia
12/19/2006	US7151103 A serotonin receptor antagonists for therapeutic treatment
12/19/2006	US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases
12/19/2006	US7151098 Glutamate receptor antagonists
12/19/2006	US7151097 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof
12/19/2006	US7150983 Modified proteolytic enzyme for treatment of osteoarthritis
12/19/2006	US7150976 Regulation of human serine-threonine protein kinase
12/19/2006	CA2358062C Controlled release galantamine composition
12/19/2006	CA2251623C Buccal delivery system
12/19/2006	CA2194761C Immunomodulatory oligonucleotides
12/19/2006	CA2155200C Use of topical anesthetics for the treatment of eosinophil-associated diseases
12/19/2006	CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/14/2006	WO2006133393A1 Treatment of sleep-wake disorders
12/14/2006	WO2006133164A2 Anti-trkb monoclonal antibodies and uses thereof
12/14/2006	WO2006132811A2 Ampa receptor potentiators
12/14/2006	WO2006132442A1 Vitamin d-like compound
12/14/2006	WO2006132438A1 1,3-benzothiazinone derivative and use thereof
12/14/2006	WO2006132432A1 Therapeutic agent for neurogenic pain
12/14/2006	WO2006132360A1 Sugar-coated tablet
12/14/2006	WO2006132307A1 Stabilized milnacipran formulation
12/14/2006	WO2006132275A1 Prophylactic and/or therapeutic agent for motor disorder
12/14/2006	WO2006132261A1 Therapeutic agent and/or prophylactic agent for neurogenic pain
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006132192A1 Novel 2-quinolone derivative
12/14/2006	WO2006132189A1 Screening method for neuronal differentiation inducer
12/14/2006	WO2006131953A2 Antibodies directed against the myelin basic protein recognising an epitope of cd64 and their use as immunosuppressants
12/14/2006	WO2006131923A2 Novel salts of conjugated psychotropic drugs and processes of preparing same
12/14/2006	WO2006131713A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	WO2006131711A1 Cyclohexanesulfonyl derivatives as glyt1 inhibitors to treat schizophrenia
12/14/2006	WO2006131525A1 3 -aryloxy- 8 -aza-bicyclo [3.2.1.] oct- 6- ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/14/2006	WO2006131524A1 Novel n-phenyl-piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/14/2006	WO2006131392A1 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/14/2006	WO2006131186A1 Oxindoles as kinase inhibitors
12/14/2006	WO2006130949A1 Anti amyloid-related disease molecules and their uses
12/14/2006	WO2006111776A3 Pharmaceutical composition comprising serum obtained from a naive mammal
12/14/2006	WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists
12/14/2006	WO2006107948A3 Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents
12/14/2006	WO2006094246A3 N-arylmethyl benzamide sirtuin modulators
12/14/2006	WO2006092106A3 Combination of egf/ghrp-6 for neurogeneration of central nervous system
12/14/2006	WO2006082409A3 Tricyclic cytoprotective compounds
12/14/2006	WO2006081444A3 Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis
12/14/2006	WO2005123074A9 Use of a compound in the treatment of sleep disorders
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281786 Compounds having activity at 5ht2c receptor and uses thereof
12/14/2006	US20060281777 Process for preparing crystalline form I of cabergoline
12/14/2006	US20060281770 Method of treating an anxiety disorder
12/14/2006	US20060281761 Osteoporosis; oral diseases; bone disorders; atherosclerosis; antiarthritic agents; autoimmune disease; cachexia
12/14/2006	US20060281759 selective serotonin receptor antagonists used for the treatment of psychological disorders such as schizophrenia and bipolar disorders, as anxiolytic agents and antidepressants; improved water solubility; side effect reduction;
12/14/2006	US20060281758 used for the treatment of psychological disorders such as schizophrenia, anxiety, depression and bipolar disorder
12/14/2006	US20060281757 Phenyl sulfone derivatives and their use in the treatment of cns disorders
12/14/2006	US20060281746 neurokinin receptor 3 (NK3) antagonists; psychological disorders, inflammatory bowel disease, asthma, ischemia, Parkinson's disease; e.g. (1S,2R)-2-(4-Acetylamino-4-phenyl-piperidin-1-ylmethyl)-1-(3,4-dichlorophenyl)-cyclopropanecarboxylic acid, benzyl-methyl-amide
12/14/2006	US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
12/14/2006	US20060281738 2-Naphthylimino-1,3-thiazine derivative
12/14/2006	US20060281735 Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic
12/14/2006	US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease
12/14/2006	US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
12/14/2006	US20060281715 Phosphates of secondary alcohols
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281692 Administering 1-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate (Coelovirin A), scopolamine, cycloheximide, and/or amyloid precursor proteins; frog orchid extracts; for improving memory performance; Alzheimer's disease; high activity, low toxicity and no inhibition to cholinesterase
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281676 Agent and method for the treatment and prevention of tse and method for the production of said agent
12/14/2006	US20060281179 Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof

1 ... 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 ... 1833